The Case for PreEmptive Pharmacogenetic Screening in South Africa

dc.article.end-page14en
dc.article.start-page1en
dc.citation.doi10.3390/JPM14010114en
dc.contributor.authorT Hurrellen
dc.contributor.authorJ Naidooen
dc.contributor.authorCollen Masimirembwaen
dc.contributor.authorJanine Scholefielden
dc.date.accessioned2024-10-08T11:20:02Z
dc.date.available2024-10-08T11:20:02Z
dc.departmentSYDNEY BRENNER INSTITUTE FOR MOLECULAR BIOSCIENCEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2075-4426en
dc.identifier.urihttps://hdl.handle.net/10539/41452
dc.journal.titleThe Case for PreEmptive Pharmacogenetic Screening in South Africaen
dc.journal.volume14en
dc.titleThe Case for PreEmptive Pharmacogenetic Screening in South Africaen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
559.44 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client